title: [Treatment of anemia in chronic kidney disease--position statement of the Croatian Society for Nephrology, Dialysis and Transplantation and review of the KDIGO and ERPB guidelines].
abstract: Renal anemia is the result of chronic kidney disease (CKD) and deteriorates with disease progression. Anemia may be the first sign of kidney disease. In all patients with anemia and CKD, diagnostic evaluation is required. Prior to diagnosing renal anemia, it is necessary to eliminate the other possible causes. Direct correlation between the concentration of hemoglobin and the stage of renal failure is well known. Early development of anemia is common in diabetic patients. Correction of anemia may slow the progression of CKD. Anemia is an independent risk factor for developing cardiovascular disease in patients with CKD. Treatment of anemia in patients with CKD is based on current guidelines. Recently, the Kidney Disease: Improving Global Outcomes (KDIGO) group has produced comprehensive clinical practice guidelines for the management of anemia in CKD patients and ERBP (European Renal Best Practice) group its position statement and comments on the KDIGO guidelines. The Croatian Society of Nephrology, Dialysis and Transplantation (HDNDT) has already published its own guidelines based on the recommendations and positive experience of European and international professional societies, as well as on own experience. The latest version of Croatian guidelines was published in 2008. Since then, on the basis of research and clinical practice, there have been numerous changes in the modern understanding of the treatment of anemia in CKD. Consequently, HDNDT hereby publishes a review of the recent recommendations of international professional societies, expressing the attitude about treating anemia in CKD as a basis for new guidelines tailored to the present time.
authors.forename: Sanjin
authors.initials: S
authors.lastname: Rački
authors.forename: Nikolina
authors.initials: N
authors.lastname: Bašić-Jukić
authors.forename: Petar
authors.initials: P
authors.lastname: Kes
authors.forename: Dragan
authors.initials: D
authors.lastname: Ljutić
authors.forename: Vesna
authors.initials: V
authors.lastname: Lovčić
authors.forename: Ingrid
authors.initials: I
authors.lastname: Prkačin
authors.forename: Josipa
authors.initials: J
authors.lastname: Radić
authors.forename: Božidar
authors.initials: B
authors.lastname: Vujičić
authors.forename: Ivan
authors.initials: I
authors.lastname: Bubić
authors.forename: Marko
authors.initials: M
authors.lastname: Jakić
authors.forename: Žarko
authors.initials: Ž
authors.lastname: Belavić
authors.forename: Siniša
authors.initials: S
authors.lastname: Sefer
authors.forename: Mario
authors.initials: M
authors.lastname: Pehai
authors.forename: Dragan
authors.initials: D
authors.lastname: Klarić
authors.forename: Marijana
authors.initials: M
authors.lastname: Gulin
mesh_terms: D005260:Female; D006801:Humans; D000740:Anemia / Q000209:etiology / Q000517:prevention & control / Q000628:therapy; D017523:Croatia; D019468:Disease Management; D018450:Disease Progression; D019317:Evidence-Based Medicine; D009398:Nephrology / Q000592:standards; D017410:Practice Guidelines as Topic / Q000592:standards; D011785:Quality Assurance, Health Care / Q000592:standards; D006435:Renal Dialysis / Q000009:adverse effects / Q000379:methods; D051436:Renal Insufficiency, Chronic / Q000150:complications / Q000628:therapy